Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Seizures Topic Center

News
Researchers Uncover Genetic Cause of Difficult-to-Treat Childhood Epilepsy Syndrome
10/18/2018
Investigators have found that pathogenic variants in a specific gene cause developmental and epileptic encephalopathies with contractures, macrocephaly, and dyskinesias.
Investigators have found that pathogenic variants in a specific gene cause developmental and epileptic encephalopathies with contractures, macrocephaly, and dyskinesias.
Investigators have found that...
10/18/2018
Neurology
News
FDA Approves Antiseizure Drug for Treatment of Severe Form of Epilepsy
08/22/2018
The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.
The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.
The FDA has approved a new drug...
08/22/2018
Neurology
Top Papers
Children With an Identified Cause of Epilepsy Have a Poorer Response to Treatment
06/07/2018
If health care providers are aware that having an identified cause of epilepsy is associated with poor response to treatment, appropriate counseling and management strategies can be established.
If health care providers are aware that having an identified cause of epilepsy is associated with poor response to treatment, appropriate counseling and management strategies can be established.
If health care providers are...
06/07/2018
Neurology
News
Integrative Medicine Should Be Used in Epilepsy
05/07/2018
In addition to traditional medications, Ann Marie Collier, MD, from Moab Regional Hospital in Colorado, says that integrative medication could be added to the treatment regimen. Read more about her session at the AAN’s 2019 Annual Meeting...
In addition to traditional medications, Ann Marie Collier, MD, from Moab Regional Hospital in Colorado, says that integrative medication could be added to the treatment regimen. Read more about her session at the AAN’s 2019 Annual Meeting...
In addition to traditional...
05/07/2018
Neurology
News
FDA Panel Votes to Recommend Cannabis-Based Epilepsy Drug
04/20/2018
Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy.
Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy.
Based on evidence from several...
04/20/2018
Neurology
News
Epilepsy Patients Have Higher Risk of Unnatural Death
04/10/2018
Epilepsy is known to be associated with an increased risk of mortality, but less is known about the unnatural cause-specific risks of mortality in this patient population.
Epilepsy is known to be associated with an increased risk of mortality, but less is known about the unnatural cause-specific risks of mortality in this patient population.
Epilepsy is known to be...
04/10/2018
Neurology
News
Anti-Seizure Drugs May Raise Alzheimer Risk
04/10/2018
Using public health register and insurance data, the authors of a recent study investigated the risk of dementia and Alzheimer disease in 2 large cohorts of individuals who used antiepileptic drugs.
Using public health register and insurance data, the authors of a recent study investigated the risk of dementia and Alzheimer disease in 2 large cohorts of individuals who used antiepileptic drugs.
Using public health register and...
04/10/2018
Neurology
News
Cannabis May Effectively Treat Drug-Resistant Epilepsy
03/07/2018
In a recent systematic review, researchers evaluated data from 36 studies regarding the safety, efficacy, and tolerability of pharmaceutical-grade cannabidiol for the treatment of drug-resistant epilepsy in children.
In a recent systematic review, researchers evaluated data from 36 studies regarding the safety, efficacy, and tolerability of pharmaceutical-grade cannabidiol for the treatment of drug-resistant epilepsy in children.
In a recent systematic review,...
03/07/2018
Neurology
News
FDA Approves the First Smart Watch for Managing Epilepsy
02/07/2018
The US Food and Drug Administration has recently approved a new smart watch that can monitor seizure activity and alert caregivers.
The US Food and Drug Administration has recently approved a new smart watch that can monitor seizure activity and alert caregivers.
The US Food and Drug...
02/07/2018
Neurology
News
Could the Ketogenic Diet Treat Refractory Status Epilepticus?
12/05/2017
The ketogenic diet has been found to be a viable treatment option for drug-resistant epilepsy in children. Researchers sought to determine if this diet could also improve symptoms among patients with refractory status epilepticus in a recent...
The ketogenic diet has been found to be a viable treatment option for drug-resistant epilepsy in children. Researchers sought to determine if this diet could also improve symptoms among patients with refractory status epilepticus in a recent...
The ketogenic diet has been...
12/05/2017
Neurology

Advertisement

Advertisement

News

Systematic Review Finds Problems With Epilepsy Outcome Prediction Models
News
Systematic Review Finds Problems With Epilepsy Outcome Prediction Models
10/10/2024
Treatment outcome prediction models for patients with newly diagnosed epilepsy have a universally high risk of bias, researchers reported in a systematic review of nearly 50 such models published in the journal Epilepsia.
Treatment outcome prediction models for patients with newly diagnosed epilepsy have a universally high risk of bias, researchers reported in a systematic review of nearly 50 such models published in the journal Epilepsia.
Treatment outcome prediction...
10/10/2024
Neurology
Sleep Disorders Linked With Epilepsy in Older Adults
News
Sleep Disorders Linked With Epilepsy in Older Adults
05/07/2024
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen...
05/07/2024
Neurology
Prenatal Exposure to Antiseizure Medications May Not Increase Risk of Epilepsy in Children
News
Prenatal Exposure to Antiseizure Medications May Not Increase Risk of Epilepsy in Children
03/05/2024
No association was found between exposure to antiseizure medications (ASMs), including valproate, during pregnancy and children developing epilepsy, in a recent prospective, population-based register cohort study results published in JAMA...
No association was found between exposure to antiseizure medications (ASMs), including valproate, during pregnancy and children developing epilepsy, in a recent prospective, population-based register cohort study results published in JAMA...
No association was found between...
03/05/2024
Neurology
Odds of Epilepsy with Moderate Traumatic Brain Injury Higher in Nondeployed Veterans
News
Odds of Epilepsy With Moderate Traumatic Brain Injury Higher in Nondeployed Veterans
12/18/2023
The risk of epilepsy in post-9/11 US veterans with moderate or severe traumatic brain injury (TBI) is higher in those who were not deployed compared with those who were deployed, according to study findings published online ahead of print...
The risk of epilepsy in post-9/11 US veterans with moderate or severe traumatic brain injury (TBI) is higher in those who were not deployed compared with those who were deployed, according to study findings published online ahead of print...
The risk of epilepsy in...
12/18/2023
Neurology
Cerebellum Identified as Source of Generalized Convulsive Seizures
News
Cerebellum Identified as Source of Generalized Convulsive Seizures
08/21/2023
The cerebellum contributes to generalized convulsive seizures by altering the activity of a specific group of neurons in the midbrain that subsequently initiates the seizures, new study results suggest.
The cerebellum contributes to generalized convulsive seizures by altering the activity of a specific group of neurons in the midbrain that subsequently initiates the seizures, new study results suggest.
The cerebellum contributes to...
08/21/2023
Neurology
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
News
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
08/14/2023
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did...
08/14/2023
Neurology
News
For Pediatric Drug-Resistant Epilepsy, Modified Atkins May Be Best Dietary Intervention
02/07/2023
Although the ketogenic diet, modified Atkins diet, and low glycemic index therapy were each more effective than care as usual for short-term seizure reduction in childhood drug-resistant epilepsy, the modified Atkins diet may be the most...
Although the ketogenic diet, modified Atkins diet, and low glycemic index therapy were each more effective than care as usual for short-term seizure reduction in childhood drug-resistant epilepsy, the modified Atkins diet may be the most...
Although the ketogenic diet,...
02/07/2023
Neurology
News
Modified Atkins Diet Plus Medication Reduces Seizures in Drug-Resistant Epilepsy
01/09/2023
Combining a modified Atkins diet with medication reduced seizures and improved quality of life in adolescents and adults with drug-resistant epilepsy, according to findings from a randomized controlled trial published in Neurology.
Combining a modified Atkins diet with medication reduced seizures and improved quality of life in adolescents and adults with drug-resistant epilepsy, according to findings from a randomized controlled trial published in Neurology.
Combining a modified Atkins diet...
01/09/2023
Neurology
News
Bidirectional, Long-term Relationship Found Between Epilepsy and Depression
12/13/2022
The bidirectional association between depression and epilepsy is a long-term relationship, according to a large-scale cohort study published in the journal Neurology.
The bidirectional association between depression and epilepsy is a long-term relationship, according to a large-scale cohort study published in the journal Neurology.
The bidirectional association...
12/13/2022
Neurology
News
Prenatal Exposure to Antiseizure Medications May Increase Risk of Autism and Intellectual Disability
06/07/2022
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure...
06/07/2022
Neurology
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement